Predictions
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.80
04.04.23
04.04.23
-
04.04.24
04.04.24
-37.04%
31.01.24
31.01.24
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€4.00
02.12.23
02.12.23
€5.00
31.10.25
31.10.25
-30.50%
10.12.23
10.12.23
Could be very worthwhile Investment >20% year
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.62
30.11.23
30.11.23
-
30.11.24
30.11.24
12.62%
08.12.23
08.12.23
Could be very worthwhile Investment >20% year
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.20
28.10.23
28.10.23
€8.00
28.10.24
28.10.24
-4.07%
11.11.23
11.11.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
negative Cash Flow expected
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€218.90
25.10.22
25.10.22
€190.00
25.10.23
25.10.23
11.47%
26.10.23
26.10.23
Could be worthwhile Investment >10% per year
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€59.10
05.10.23
05.10.23
-
05.10.24
05.10.24
-8.93%
15.10.23
15.10.23
Could be worthwhile Investment >10% per year
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.60
30.09.23
30.09.23
€9.00
30.09.24
30.09.24
11.22%
14.10.23
14.10.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.00
16.09.23
16.09.23
€12.00
16.09.24
16.09.24
-13.33%
30.09.23
30.09.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
negative Cash Flow expected
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€25.20
15.09.23
15.09.23
-
15.09.24
15.09.24
-4.76%
16.09.23
16.09.23
Could be very worthwhile Investment >20% year
Nektar Therapeutics
Start price
Target price
Perf. (%)
€0.95
07.08.23
07.08.23
-
07.08.24
07.08.24
-29.26%
19.08.23
19.08.23
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€15.10
07.08.23
07.08.23
-
07.08.24
07.08.24
21.19%
18.08.23
18.08.23
Capable Management
Risky Investment
No uniques
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€51.50
16.08.22
16.08.22
-
16.08.23
16.08.23
-27.77%
16.08.23
16.08.23
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€104.86
16.08.22
16.08.22
-
16.08.23
16.08.23
-6.73%
16.08.23
16.08.23
Global Blood Therapeutics Inc
Start price
Target price
Perf. (%)
€64.36
10.08.22
10.08.22
-
10.08.23
10.08.23
6.49%
10.08.23
10.08.23
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.10
10.08.22
10.08.22
-
10.08.23
10.08.23
3.34%
10.08.23
10.08.23
Fibrogen Inc.
Start price
Target price
Perf. (%)
€2.48
26.06.23
26.06.23
-
26.06.24
26.06.24
-1.61%
08.07.23
08.07.23
Probably not worthwhile Investment
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€34.22
22.05.22
22.05.22
-
22.05.23
22.05.23
-1.45%
22.05.23
22.05.23
Repligen Corp.
Start price
Target price
Perf. (%)
€264.10
27.11.21
27.11.21
€300.00
31.12.23
31.12.23
-46.31%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Bruker Corp.
Start price
Target price
Perf. (%)
€75.50
27.11.21
27.11.21
€100.00
31.12.23
31.12.23
-5.30%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Acceleron Pharma Inc.
Start price
Target price
Perf. (%)
€149.00
30.10.21
30.10.21
€180.00
31.12.23
31.12.23
6.71%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year